tiprankstipranks
Amphastar Pharmaceuticals (DE:29A)
FRANKFURT:29A
Germany Market

Amphastar Pharmaceuticals (29A) Cash flow

Compare
0 Followers

Amphastar Pharmaceuticals Cash Flow

DE:29A's free cash flow for Q4 2024 was $16.61M. For the 2024 fiscal year, DE:29A's free cash flow was decreased by $27.01M and operating cash flow was $29.02M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 213.39M$ 183.50M$ 89.18M$ 97.99M$ 57.27M
Investing Cash Flow
$ -124.93M$ -649.12M$ -32.78M$ -28.67M$ -36.41M
Financing Cash Flow
$ -80.95M$ 454.09M$ -26.44M$ -37.02M$ -2.25M
End Cash Position
$ 151.84M$ 144.53M$ 156.33M$ 126.59M$ 94.51M
Free Cash Flow
$ 172.34M$ 145.34M$ 65.15M$ 70.54M$ 23.41M
Currency in USD

Amphastar Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis